The Industry Standard: Intelligence for the Information Economy

  September 5, 2001
  NEWS & ANALYSIS
   Headlines
   Money & Markets
   Tech & Telecom
   Media & Marketing
   Metrics & Stats
   Policy & Politics
  SEARCH
   
  advanced search
  SERVICES
   Company Index
   Newsletters
   Wireless
  PRINT EDITION
   Read the Magazine

Home > Company Index > Drugs > Biotechnology-Medicine > XOMA Ltd.

XOMA Ltd.
Nasdaq: XOMA
Change
symbol:
     
 NEWS FROM THE WIRES
Genentech's Xanelim effective for psoriasis - study
Jul 30 2001 09:11 PM PDT

More WIRE STORIES about this company

 PROFILE
XOMA isn't exactly zooming along the drug development path. The company's lead drug candidate, NEUPREX, has suffered setbacks as a potential treatment for bacterial infections related to severe blood loss and for childhood meningococcemia. Other products in XOMA's pipeline include Xanelim, a psoriasis and transplant rejection drug candidate it is developing with Genentech; head and neck cancer therapy CI-1042; and Genimune, which targets certain types of lymphomas as well as rheumatoid arthritis and other autoimmune diseases. In addition to Genentech, XOMA has development agreements with such firms as Baxter International and Onyx Pharmaceuticals.

 COMPETITION
Biogen, Inc. (BGEN)
Immunex Corporation (IMNX)
Medarex, Inc. (MEDX)

 STOCK ANALYSIS
 View by:
 Day 
 Day 
 Month 
 Month 
 Year 
 Year 
FURTHER ANALYSIS
• Advanced Charting
• Deals

 FINANCIAL OVERVIEW
Fiscal Year-End: December
2000 Sales (mil.): 6.70
1-Yr. Sales Growth: 179.2%
Employees: 161
Revenue per employee: $41,614.91

 KEY PEOPLE
• John L. Castello
    CEO
• Peter B. Davis
    CFO

 CONTACT INFO
2910 7th St.
Berkeley, CA 94710
US
Phone: 510-644-1170
Fax: 510-644-0471
Online: Web Site

Company Data   News, quotes & more       

Hoovers Online   Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.


ADVERTISEMENT
FEATURED LINKS
Home |  Customer Service |  About Us
Australia |  Brazil |  China |  Korea |  Norway |  Poland |  Sweden |  Taiwan

Copyright ©2001 Standard Media International. Privacy Policy
Stock data provided by Stockpoint and its data suppliers. Copyright © 1995-2001